Memorial Sloan-Kettering Cancer Center at Commack

Commack, New York 11725

0 studies enrolling now · 34 studies all time

What they study most

Acute Myeloid Leukemia, Brain Cancer, Breast Cancer, Breast Cancer Survivor, CD34 Selected Peripheral Blood Stem Cell Graft, CNS Cancer, Cancer Patients First-ever Acute Ischemic Stroke, Cholangiocellular Carcinoma) (ICC), Cholangiolar Carcinoma, Diffuse Large B-Cell Lymphoma, Diffuse Large B-cell Lymphoma, Erectile Dysfunction

Studies at this site

• Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma — Running, not enrolling
• Meclofenamate in Subjects With Recurrent or Progressive Brain Metastasis From Solid Tumor Primary — Running, not enrolling
• Group Interventions for Breast Cancer Survivors — Running, not enrolling
• Communication Skills Intervention to Promote Transition Into Survivorship — Running, not enrolling
• Regorafenib in Good Performance Status Patients With Newly Diagnosed Metastatic Colorectal Adenocarcinoma — Completed
• Implantable Microdevice for In Vivo Drug Sensitivity Testing in Patients With Early Stage, HER2-Positive or Triple Negative Breast Cancer — Completed
• Geriatric Assessment and Nursing Telephone Intervention in Elderly Women With Ovarian Cancer — Completed
• PF-06863135 As Single Agent And In Combination With Immunomodulatory Agents In Relapse/Refractory Multiple Myeloma — Completed
• Romidepsin in Combination With Lenalidomide in Adults With Relapsed or Refractory Lymphomas and Myeloma — Completed
• Early Onset and Familial Gastric Cancer Registry — Completed
• A Clinical Trial to Learn About the Study Medicine Called Maplirpacept (PF-07901801), Alone and When Used in Combination With Other Medicines to Treat Participants With Advanced Hematological Malignancies, Including Lymphoma, Leukemia and Multiple Myeloma — Stopped early
• BRAF Inhibitor, LGX818, Utilizing a Pulsatile Schedule in Patients With Stage IV or Unresectable Stage III Melanoma Characterized by a BRAFV600 Mutation — Completed
• Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography To Detect Hypoxia in Head and Neck Cancer Patients — Completed
• EGFR Inhibition Using Weekly Erlotinib for Recurrent Malignant Gliomas — Completed
• Chemotherapy-Induced Changes to Cognition and DNA in Breast Cancer Survivors — Completed
• Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Gemcitabine as Adjuvant Treatment After Resection of Intrahepatic Cholangiocarcinoma — Completed
• Enoxaparin Versus Aspirin in Patients With Cancer and Stroke — Completed
• A Collection of Clinical and Epidemiologic Data Combined With Tissue and Blood From Patients With a Diagnosis of Neuroendocrine Tumors — Completed
• A Study to Assess Thymic Function Using PET/CT and MRI — Completed
• Temozolomide & RT Followed by Dose Dense vs Temozolomide & Retinoic Acid in Pts w/Glioblastoma — Completed
• Bevacizumab, Temozolomide and Hypofractionated Radiotherapy for Patients With Newly Diagnosed Malignant Glioma — Completed
• Cetuximab at Either 500 or 750 mg/m2 Every Other Week for Recurrent or Metastatic Head and Neck Squamous Cell Cancer — Completed
• Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer — Completed
• Combination of the Hedgehog Inhibitor, LDE225, With Etoposide and Cisplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) — Completed
• Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer — Completed
• Dose Dense Adjuvant CMF (Cyclophosphamide, Methotrexate, Fluorouracil) at 14 and 10-11 Day Intervals for Women With Early Stage Breast Cancer — Completed
• Bevacizumab, Cetuximab, and Cisplatin With IMRT (Intensity-Modulated Radiation Therapy) for Patients With Stage III/IV Head and Neck Squamous Cell Carcinoma — Completed
• Temozolomide for Relapsed Sensitive or Refractory Small Cell Lung Cancer — Completed
• Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma — Completed
• Study of Biweekly Capecitabine Dosing With Bevacizumab for the Treatment of Metastatic Breast Cancer Based Upon the Norton-Simon Mathematical Model — Completed
• Open-label Study of STA-9090 for Patients With Metastatic Breast Cancer — Completed
• Docetaxel + Cetuximab + Concurrent Re-Irradiation (Intensity - Modulated Radiation Therapy, IMRT) for Patients With Locoregionally Recurrent Head and Neck Cancer — Completed
• Physician-Patient Communication About Breast Cancer-Related Internet Information and Its Effect on Patient Satisfaction and Anxiety — Completed
• RAD001 (Everolimus) + Docetaxel + Cisplatin as Induction Chemotherapy in Patients With Local-Regional Advanced Head and Neck Cancer — Completed